Stryker’s Rejuvenate and ABG II hip replacement implants have been recalled because of their faulty design which causes various problems in users. These two hip replacement implants have been found to have high failure rates. It produces tiny metal fragments due the friction between the metal ball-and-socket, resulting to higher-than-usual levels of metals in the bloodstream. Since their recall, Stryker had announced that the recall may potentially cost them $140 million to $390 million. However, the hip replacement manufacturer has increased the amount of allocation for the patients’ necessary treatment, as well as the settlement of claims for insurance payments and lawsuits. Financial analysts continue to keep to close tab on the fluctuations of Stryker’s stock price.
(PRWEB) April 06, 2013
A Massachusetts woman filed on March 26 what is believed to be the first federal Stryker ABG II Hip Lawsuit in the nation, according to court records. The Rottenstein Law Group, a Stryker hip recall law firm, will follow the case closely and maintains a Stryker Hip Replacement Recall Center with information on Stryker side effects and Stryker lawsuits, as well as news updates.
Plaintiffs Lisa and Brett Lincoln filed the lawsuit (Lincoln et al v. Howmedica Osteonics Corp., d/b/a Stryker Orthopeadics, 1:13-cv-10689-WGY, U.S. District Court for the District of Massachusetts) seeking damages related to what they allege is a defective device, according to court documents.
“There are already several Stryker hip lawsuits pending regarding the company’s Rejuvenate hip replacement,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “That someone filed a federal lawsuit regarding the ABG II hip stem implant is then perhaps not surprising.”
Read full story at PRWeb: Stryker Hip Replacement Lawsuit News: Mass. Woman Files First Known Federal Stryker ABG II Hip Lawsuit, Rottenstein Law Group Reports